Works matching IS 13657852 AND DT 2006 AND VI 9 AND IP 1

Results: 19

Brn-3a neuronal transcription factor functional expression in human prostate cancer.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 83, doi. 10.1038/sj.pcan.4500837
By:
- Diss, J. K. J.;
- Faulkes, D. J.;
- Walker, M. M.;
- Patel, A.;
- Foster, C. S.;
- Budhram-Mahadeo, V.;
- Djamgoz, M. B. A.;
- Latchman, D. S.
Publication type:
Article
Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 77, doi. 10.1038/sj.pcan.4500848
By:
- Altinok, G.;
- Powell, I. J.;
- Che, M.;
- Hormont, K.;
- Sarkar, F. H.;
- Sakr, W. A.;
- Grignon, D.;
- Liao, D. J.
Publication type:
Article
PSA testing: an evolving relationship with prostate cancer screening.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 6, doi. 10.1038/sj.pcan.4500838
By:
- Constantinou, J.;
- Feneley, M. R.
Publication type:
Article
Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 92, doi. 10.1038/sj.pcan.4500843
By:
- Kalkner, K. M.;
- Acosta, S.;
- Thorsson, O.;
- Frederiksen, H.;
- Nilsson, A.;
- Gustavsson, B.;
- Elingsbo, M.;
- Stridsberg, M.;
- Abrahamsson, P-A.
Publication type:
Article
Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 39, doi. 10.1038/sj.pcan.4500833
By:
- Ferreira, U.;
- Leitao, V. A.;
- Denardi, F.;
- Matheus, W. E.;
- Stopiglia, R. M.;
- Netto Jr, N. R.
Publication type:
Article
Quantitative expression profile of PSGR in prostate cancer.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 56, doi. 10.1038/sj.pcan.4500836
By:
- Xu, L. L.;
- Sun, C.;
- Petrovics, G.;
- Makarem, M.;
- Furusato, B.;
- Zhang, W.;
- Sesterhenn, I. A.;
- McLeod, D. G.;
- Sun, L.;
- Moul, J. W.;
- Srivastava, S.
Publication type:
Article
Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 50, doi. 10.1038/sj.pcan.4500840
By:
- Beebe-Dimmer, J. L.;
- Lange, L. A.;
- Cain, J. E.;
- Lewis, R. C.;
- Ray, A. M.;
- Sarma, A. V.;
- Lange, E. M.;
- Cooney, K. A.
Publication type:
Article
Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 14, doi. 10.1038/sj.pcan.4500839
By:
- Gould, D. C.;
- Kirby, R. S.
Publication type:
Article
Watchful waiting for prostate cancer: a review article.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 25, doi. 10.1038/sj.pcan.4500857
By:
- Chodak, G. W.;
- Warren, K. S.
Publication type:
Article
Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partners.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 30, doi. 10.1038/sj.pcan.4500841
By:
- Roehrborn, C. G.;
- Marks, L.;
- Harkaway, R.
Publication type:
Article
Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 62, doi. 10.1038/sj.pcan.4500842
By:
- Hu, C. K.;
- McCall, S.;
- Madden, J.;
- Huang, H.;
- Clough, R.;
- Jirtle, R. L.;
- Anscher, M. S.
Publication type:
Article
Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 68, doi. 10.1038/sj.pcan.4500845
By:
- Haddad, A. Q.;
- Venkateswaran, V.;
- Viswanathan, L.;
- Teahan, S. J.;
- Fleshner, N. E.;
- Klotz, L. H.
Publication type:
Article
The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 19, doi. 10.1038/sj.pcan.4500844
By:
- Ribeiro, R.;
- Lopes, C.;
- Medeiros, R.
Publication type:
Article
Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 35, doi. 10.1038/sj.pcan.4500846
By:
- Yaturu, S.;
- DjeDjos, S.;
- Alferos, G.;
- Deprisco, C.
Publication type:
Article
Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit?
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 42, doi. 10.1038/sj.pcan.4500858
By:
- Harris, M. R. E.;
- Speakman, M. J.
Publication type:
Article
Report from Durham.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 1, doi. 10.1038/sj.pcan.4500863
By:
- Moul, J. W.
Publication type:
Article
Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 45, doi. 10.1038/sj.pcan.4500847
By:
- Stamatiou, K.;
- Alevizos, A.;
- Perimeni, D.;
- Sofras, F.;
- Agapitos, E.
Publication type:
Article
Prostate News.
Published in:
Prostate Cancer & Prostatic Diseases, 2006, v. 9, n. 1, p. 2, doi. 10.1038/sj.pcan.4500864
Publication type:
Article
Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach.
Published in:
2006
By:
- Mouraviev, V.;
- Evans, B.;
- Polascik, T. J.
Publication type:
Case Study